Minneapolis, MNNCT05426083Now EnrollingIRB Ready

Acute Coronary Syndrome Clinical Trial in Minneapolis, MN

Access cutting-edge acute coronary syndrome treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.

Sponsored by University of Minnesota

Quick Self-Assessment

See if you qualify for this Minneapolis location

Preparing your pre-screening questions…

Expert Care in Minneapolis

Access acute coronary syndrome specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acute coronary syndrome treatment provided free

Apply for This Minneapolis Location

Check if you qualify for this acute coronary syndrome clinical trial in Minneapolis, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minneapolis

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minneapolis site if eligible
  4. 4Begin participation

About This Acute Coronary Syndrome Study in Minneapolis

A Clinical Events Committee (CEC) will include Cardiac Surgery Professor and chief of cardiac surgery Rose Kelly MD, Professor of Medicine Ganesh Raveendran MD at the University of Minnesota who is the direction of Interventional Cardiology and Professor of Medicine at the University of Minnesota David Benditt. They will review and adjudicate serious and unexpected adverse events independently from the PI and co investigators.

Sponsor: University of Minnesota

Who Can Participate

Inclusion Criteria

Age 18-75 years
SCAI D/E CS requiring VA-ECMO support based on treating team's judgement.
MAP \>65 mmHg on \<3 vasopressors/inotropes at the time of consent
Cardiogenic shock due to acute coronary syndrome identified by coronary angiography at the index hospitalization per standard cardiology practice

Exclusion Criteria

VA-ECMO for sepsis, pulmonary embolism, COVID-19 related cardiorespiratory failure, severe RV failure due to severe idiopathic pulmonary hypertension
CS due to other (non-ACS) etiologies
Known patient with severe left ventricular dysfunction and stage IV NYHA heart failure being evaluated for or with a history of LVAD and transplantation prior to commencement of VA-ECMO
Profound vasoplegia with MAP \<65 mmHg on 3 vasopressors/inotropes
Moderate to severe aortic regurgitation (contraindication to VA-ECMO)
Moderate to severe aortic stenosis (contraindication to LV instrumentation with PV loop catheter)
Bleeding complications requiring ongoing transfusions of blood products
Ischemic lower extremities
Evidence of circuit thrombosis or fibrin accumulation (turndown increases risk for stroke and clot formation)
Evidence of sepsis or septic shock
Evidence of LV thrombus on echocardiography (contraindication for accessing LV cavity with catheters)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minneapolis?

Yes, this clinical trial (NCT05426083) has an active research site in Minneapolis, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acute Coronary Syndrome Treatment Options in Minneapolis, MN

If you're searching for acute coronary syndrome treatment options in Minneapolis, MN, this clinical trial (NCT05426083) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute coronary syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all acute coronary syndrome clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Minneapolis, MN

See all heart attack clinical trials recruiting in Minneapolis — not just this study.

Browse Heart Attack Trials in Minneapolis →

Browse More Trials by Condition

Heart Attack TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Minneapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minneapolis, MN